PDE9A decreases PKG activity through the hydrolysis of cGMP, whereas the stimulation of cGMP/PKG signaling can suppress Wnt/β-catenin transcription, inhibit the proliferation of cancer cells, and enhance tumor immunity [35]. Here, PRKG1 is linked to cancer.